Skip to content
    Venrock logo

    Venrock

    Palo Alto, California, United StatesFounded 1969

    Venrock is a venture capital firm that primarily focuses on early-stage investments in disruptive technology and healthcare companies. Their strategy involves backing innovative startups, often leading seed and Series A rounds, with a hands-on approach to provide strategic guidance.

    Deal activity increased 150% year-over-year (5 deals in the last 12 months). Average disclosed round size is $53.1M (across 77 rounds with reported amounts).

    Find people at Venrock on Goldilocks AI

    Portfolio

    80

    Fund Size

    Top Stage

    Series A

    Last 12 Mo

    5

    Team

    DB

    Dr. Bob Kocher

    Partner

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    80 investments
    CompanyRoundAmountDate
    GenLogs logoGenLogsSeries B$60MFeb 2026
    Finny logoFinnySeries A$17MDec 2025
    Euclid Power logoEuclid PowerSeries A$20MSep 2025
    Adyton logoAdytonSeries A$11MMay 2025
    Astronomer logoAstronomerSeries D$93MMay 2025
    GenLogs logoGenLogsSeries A$14.6MFeb 2025
    Tembo logoTemboSeries A$14MJul 2024
    Accompany Health logoAccompany HealthSeries A$56MJan 2024
    Aledade logoAledadeGrowth$260MJun 2023
    NNightfall AISeries B$40MAug 2022
    Dgraph logoDgraphSeed$6MJul 2022
    MMeltanoSeed$8.2MJun 2022
    VVanillaSeries B$30MApr 2022
    Astronomer logoAstronomerSeries C$213MMar 2022
    SmithRx logoSmithRxSeries B$20MMar 2022
    Astrix Security logoAstrix SecuritySeed$15MFeb 2022
    Stride Health logoStride HealthSeries C$47MOct 2021
    Skyryse logoSkyryseSeries B$205MOct 2021
    RRebellion DefenseSeries D$150MSep 2021
    Porter logoPorterSeed$1.5MJul 2021
    Atom Computing logoAtom ComputingSeries A$15MJul 2021
    RRaribleSeries A$14.2MJun 2021
    Astranis logoAstranisSeries C$250MApr 2021
    TAE Technologies logoTAE TechnologiesGrowth$280MApr 2021
    Amunix Pharmaceuticals, Inc. logoAmunix Pharmaceuticals, Inc.Series B$117MMar 2021
    Page 1 of 4

    Top Co-Investors

    Last updated: 12 April 2026